These observations indicated that the expression of ERs mRNAs was heterogeneous and did not coincide with that observed in EZH2 mRNA (Supplementary Figure 5), suggesting that ERs and EZH2 expressions are not related in gliomas progression. This evidence concerns the gene EZH2 and central nervous system cancer.